Rick brings a wealth of knowledge in medtech innovation and commercialization. His leadership has guided numerous startups through the complexities of developing and launching medical technologies, ensuring their long-term success.

With a multidisciplinary background in technology and healthcare, Andrew combines technical expertise with strategic insight. His commitment to innovation and excellence drives MedTech Angels’ mission to support game-changing startups.

Travis is a visionary entrepreneur and investor whose expertise spans domestic and international markets encompassing strategy, operations, and early-stage growth. He is passionate about empowering startups to scale successfully and create meaningful change in healthcare.

With extensive experience in healthcare operations and investment, Robert has been instrumental in fostering innovative solutions that address critical challenges in the medical industry. His strategic mindset and commitment to impactful investments are at the core of MedTech Angels’ success.

Kate Pietrovito brings deep expertise in clinical evidence strategy and execution, helping de-risk medical innovation and accelerate regulatory readiness, reimbursement, and market adoption.

Jordan Chase brings deep expertise in building and scaling high-performing commercial teams for early-stage medical device companies, accelerating go-to-market execution and reducing talent-related commercialization risk.

Jeremy Kim, MD brings deep clinical and trial-level expertise in interventional radiology and embolization therapies, helping evaluate procedural adoption, clinical differentiation, and real-world execution risk for minimally invasive medical technologies.

Tyler Wanke, MD, MBA brings a rare operator-investor perspective in medical technology, leveraging hands-on company building, board leadership, and clinical training to evaluate technical risk, capital efficiency, and commercialization potential.

David Doster brings decades of commercial leadership experience in medical technology, helping companies execute go-to-market strategy, navigate growth inflection points, and drive sustained revenue and enterprise value creation.

Danielle Bradbury brings deep operator experience across clinical, commercial, and education functions, helping early-stage medical technology companies scale adoption, optimize clinical execution, and drive durable post-sale performance.

Billy C. McCarroll brings more than two decades of operating and infrastructure experience across the U.S. and Southeast Asia, providing a disciplined, execution-focused perspective on scaling complex businesses, capital deployment, and operational risk.

Craig Scherer brings decades of medical device product development and accelerator experience, helping early-stage MedTech companies advance technical viability, attract capital, and connect with clinical and strategic partners.

Tony Arnold brings more than two decades of executive leadership in building and scaling venture-backed medical device companies, with deep expertise in capital formation, board governance, and commercialization of complex technologies.

Bruce McNulty, MD brings decades of physician executive and health system leadership experience, offering deep insight into hospital operations, clinical quality, physician alignment, and enterprise decision-making within complex healthcare organizations.

Kelleny Berchuck, PhD brings deep expertise in venture creation and scaling, having built and commercialized tech-enabled healthcare platforms that drive revenue growth, operational efficiency, and expanded patient access across global markets.

Nate Porter brings deep C-suite and private equity–backed operating experience in commercial transformation, M&A, and value creation, helping scale medical technology businesses from growth through successful exit.

Scott Peairs is a seasoned medical technology commercial leader and advisor with extensive experience driving sales, marketing, and business development for diagnostic and interventional imaging technologies, helping early-stage companies advance commercial traction and strategic partnerships.

Carson Dillashaw brings an entrepreneurial, asset-focused perspective to MedTech investing, applying disciplined business operations, risk management, and long-term value thinking to medical innovation and device development.

Joe McClung brings deep expertise in MedTech executive recruiting and commercial leadership, helping early-stage and growth-stage medical device companies build high-impact teams that accelerate commercialization and scale.